From the Tiger’s MLB site:
The fallout from Major League Baseball’s Biogenesis investigation that began in Miami and dominated headlines in New York hit Detroit and the American League Central race on Monday. In the process, it put Jhonny Peralta’s season — and his future with the Tigers — into serious question.
On Monday, MLB announced 50-game suspensions for 13 players, including Peralta, stemming from their involvement with Biogenesis, a Miami-area clinic that allegedly provided players with human growth hormone and other performance-enhancing substances. Peralta has agreed not to appeal the suspension and will begin serving it starting with Monday night’s series opener against the second-place Indians. Peralta’s All-Star season, including a .305 average, 29 doubles, 11 home runs and 54 RBIs, is on hold.
The Tigers issued a statement shortly after MLB’s announcement:
“We recognize the suspension of Jhonny Peralta for violating Major League Baseball’s Joint Drug Prevention and Treatment Program as a measure taken in the best interest of the game. The Detroit Tigers continue to fully support Major League Baseball’s policy and its efforts to eliminate performance enhancing drugs from our game. Per the protocol outlined by Major League Baseball’s collective bargaining agreement, the Tigers’ organization will provide no further comment on Peralta’s suspension.”
By not appealing his suspension, Peralta will complete the ban with three games to go in the regular season — in time for Detroit’s series against the Marlins from Sept. 27-29 — and be eligible for the postseason roster. Whether the Tigers’ front office or the team’s players want him back, or whether Peralta has played his final game in a Detroit uniform, will be a question that follows the club in the coming weeks.
Eleven other players also received the same suspension, and some guy from the Yankees is out for the rest of the season and next year once his appeal — in all senses of the word — is exhausted.
Not a good day for baseball.